Penny Stock News / Trending Stock News

How Analysts Feel About ADVANSOURCE BIOMATERIALS CORPRATION (OTCMKTS:ASNB) After Decrease in Sellers?

The stock of ADVANSOURCE BIOMATERIALS CORPRATION (OTCMKTS:ASNB) registered a decrease of 21.33% in short interest. ASNB’s total short interest was 5,900 shares in November as published by FINRA. Its down 21.33% from 7,500 shares, reported previously. With 108,800 shares average volume, it will take short sellers 0 days to cover their ASNB’s short positions.

The stock increased 0.15% or $0.0001 during the last trading session, reaching $0.0656. About 116 shares traded. AdvanSource Biomaterials Corporation (OTCMKTS:ASNB) has 0.00% since November 10, 2017 and is . It has underperformed by 15.62% the S&P500.

AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices used for treating a range of anatomical sites and disease states. The company has market cap of $1.41 million. It offers polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names. It currently has negative earnings. The firm also makes specialty hydrophilic polyurethanes.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *

*